These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35638866)

  • 21. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
    Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ; ; ;
    Nat Med; 2020 Sep; 26(9):1351-1363. PubMed ID: 32908284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study protocol for the development of a SPIRIT extension for trials conducted using cohorts and routinely collected data (SPIRIT-ROUTINE).
    McCarthy M; O'Keeffe L; Williamson PR; Sydes MR; Farrin A; Lugg-Widger F; Davies G; Avery K; Chan AW; Kwakkenbos L; Thombs BD; Watkins A; Hemkens LG; Gale C; Zwarenstein M; Langan SM; Thabane L; Juszczak E; Moher D; Kearney PM
    HRB Open Res; 2021; 4():82. PubMed ID: 34877471
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.
    Solovyeva O; Dimairo M; Weir CJ; Hee SW; Espinasse A; Ursino M; Patel D; Kightley A; Hughes S; Jaki T; Mander A; Evans TRJ; Lee S; Hopewell S; Rantell KR; Chan AW; Bedding A; Stephens R; Richards D; Roberts L; Kirkpatrick J; de Bono J; Yap C
    BMC Med; 2023 Jul; 21(1):246. PubMed ID: 37408015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE).
    Gryaznov D; von Niederhäusern B; Speich B; Kasenda B; Ojeda-Ruiz E; Blümle A; Schandelmaier S; Mertz D; Odutayo A; Tomonaga Y; Amstutz A; Pauli-Magnus C; Gloy V; Lohner S; Bischoff K; Wollmann K; Rehner L; Meerpohl JJ; Nordmann A; Klatte K; Ghosh N; Taji Heravi A; Wong J; Chow N; Hong P; McCord-De Iaco KA; Sricharoenchai S; Busse JW; Agarwal A; Saccilotto R; Schwenkglenks M; Moffa G; Hemkens L; Hopewell S; Von Elm E; Briel M
    BMJ Open; 2022 May; 12(5):e053417. PubMed ID: 35613804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extensionDiretrizes para protocolos de ensaios clínicos com intervenções que utilizam inteligência artificial: a extensão SPIRIT-AI].
    Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ; ; ;
    Rev Panam Salud Publica; 2024; 48():e12. PubMed ID: 38304411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extensionDiretrizes para protocolos de ensaios clínicos com intervenções que utilizam inteligência artificial: a extensão SPIRIT-AI].
    Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ; ; ;
    Rev Panam Salud Publica; 2023; 47():e149. PubMed ID: 38361499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study.
    Speich B; Odutayo A; Peckham N; Ooms A; Stokes JR; Saccilotto R; Gryaznov D; von Niederhäusern B; Copsey B; Altman DG; Briel M; Hopewell S
    Trials; 2022 Jul; 23(1):601. PubMed ID: 35897110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
    Espinasse A; Solovyeva O; Dimairo M; Weir C; Jaki T; Mander A; Kightley A; Evans J; Lee S; Bedding A; Hopewell S; Rantell K; Liu R; Chan AW; De Bono J; Yap C
    BMJ Open; 2023 Mar; 13(3):e068173. PubMed ID: 36990492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Give Us The Tools!': development of knowledge transfer tools to support the involvement of patient partners in the development of clinical trial protocols with patient-reported outcomes (PROs), in accordance with SPIRIT-PRO Extension.
    Cruz Rivera S; Stephens R; Mercieca-Bebber R; Retzer A; Rutherford C; Price G; Slade A; Aiyegbusi OL; Edge P; Roberts L; Gosden L; Verdi R; Wilson R; Calvert M
    BMJ Open; 2021 Jun; 11(6):e046450. PubMed ID: 34193492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018).
    Dai L; Cheng CW; Tian R; Zhong LL; Li YP; Lyu AP; Chan AW; Shang HC; Bian ZX
    Chin J Integr Med; 2019 Jan; 25(1):71-79. PubMed ID: 30484022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.
    King MT; Tait MA; Campbell R; Müller F; Rutherford C; Beckmore C; Chima S; Langbecker D; Shaw J; Mercieca-Bebber R
    Qual Life Res; 2022 Oct; 31(10):2901-2916. PubMed ID: 35553325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the reporting quality of adult neuro-oncology protocols, abstracts, and trials: Adherence to the SPIRIT and CONSORT statements.
    Suppree JS; Patel A; Keshwara SM; Krishna ST; Gillespie CS; Richardson GE; Mustafa MA; Hart S; Islim AI; Jenkinson MD; Millward CP
    Neurooncol Pract; 2023 Aug; 10(4):391-401. PubMed ID: 37457230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The SPIRIT Checklist-lessons from the experience of SPIRIT protocol editors.
    Qureshi R; Gough A; Loudon K
    Trials; 2022 Apr; 23(1):359. PubMed ID: 35477436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional study.
    Lohner S; Gryaznov D; von Niederhäusern B; Speich B; Kasenda B; Ojeda-Ruiz E; Schandelmaier S; Mertz D; Odutayo A; Tomonaga Y; Amstutz A; Pauli-Magnus C; Gloy V; Bischoff K; Wollmann K; Rehner L; Meerpohl JJ; Nordmann A; Klatte K; Ghosh N; Heravi AT; Wong J; Chow N; Hong PJ; McCord K; Sricharoenchai S; Busse JW; Agarwal A; Saccilotto R; Schwenkglenks M; Moffa G; Hemkens LG; Hopewell S; von Elm E; Blümle A; Briel M
    J Clin Epidemiol; 2021 Nov; 139():340-349. PubMed ID: 34029678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Not enough SPIRIT shown in the registration and reporting of orthodontic trial protocols.
    Eleftheriadi I; Ioannou T; Katechi V; Seehra J; Pandis N
    Eur J Orthod; 2023 Feb; 45(1):29-37. PubMed ID: 35639885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.
    Duarte RV; Bresnahan R; Copley S; Eldabe S; Thomson S; North RB; Baranidharan G; Levy RM; Taylor RS;
    Neuromodulation; 2022 Oct; 25(7):1045-1049. PubMed ID: 35088759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The reporting quality of N-of-1 trials and protocols still needs improvement.
    Wei Z; Chu X; Han J; Zhang N; Li Y; Yang C; Wang Q; Li J; Belal AA; Yan P; Li X; Yang K
    J Evid Based Med; 2022 Dec; 15(4):365-372. PubMed ID: 35919928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.